News
Touchlight, Cell and Gene Therapy Catapult and Complement Therapeutics to develop innovative manufacturing process...
The Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organisation specialising in the advancement of the cell and gene therapy...
Oregon Therapeutics & Lantern Pharma launch strategic AI collaboration to optimize development of potent...
Lantern Pharma, an artificial intelligence (AI) oncology drug discovery and development company, has formed a strategic AI-driven collaboration with French biotechnology company, Oregon Therapeutics...
New cabotegravir formulations approved to help prevent HIV-1 infection
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has approved two new formulations of the medicine cabotegravir (Apretude 30 mg film-coated tablets and...
